Registry of Lobbyists
Version 2 of 2 (1998-03-11 to 1999-02-26) was submitted prior to the Lobbying Act coming into force on July 2, 2008. Due to different information requirements at that time, the registration is presented in the following format.
| Corporation: |
SMITHKLINE BEECHAM PHARMA INC.
2030 BRISTOL CIRCLE OAKVILLE, ON L6H 5V2 Canada |
| Telephone number: | 905-829-2030 |
| Fax number: | 905-829-6076 |
| Responsible officer name and position during the period of this registration: | RHONDA HUSTLER, MANAGER, POLICY AND COMMUNICATIONS |
| Description of activities: | MANUFACTURE AND SALE OF PHARMACEUTICALS |
| The client is a subsidiary of the following parent companies: |
SMITHKLINE BEECHAM PHARMA PLC
LONDON United Kingdom |
| Coalition | The corporation is not a member of a coalition. |
| Subsidiary: | The corporation does not have any subsidiaries that could be affected by the outcome of the undertaking. |
| Other direct interests | The corporation's activities are not controlled or directed by another individual, organization or corporation with a direct interest in the outcome of this undertaking. |
| Was the corporation funded in whole or in part by any domestic or foreign government institution in the last completed financial year? | No |
| Federal departments or organizations which have been or will be communicated with during the course of the undertaking: | Health Canada (HC), Industry Canada, Patented Medicine Prices Review Board (PMPRB), Privy Council Office (PCO), Treasury Board Of Canada Secretariat (TBS) |
|
Communication techniques that have been used or are expected to be used in the course of the undertaking:
|
Grass-roots communication, Informal communications, Meetings, Presentations, Telephone calls, Written communications, whether in hard copy or electronic format |
| Subject Matter: Areas of Concern: | Consumer Issues, Environment, Health, Industry, Intellectual Property, International Trade, Science and Technology, Taxation and Finance |
| Subject Matter: Particulars: | FOOD & DRUG ACT; PATENT ACT [BILL C-91, DRUG PATENTS]; REGULATIONS RELATING TO SCIENTIFIC RESEARCH & DEVELOPMENT TAX CREDITS, HOMECARE, PHARMACARE, PRIVACY/ELECTRONIC INFORMATION, NEW DRUG APPROVAL PROCESSES, DRUG REIMBURSEMENT |